Background Inflammation plays an important role in coronary artery disease (CAD). Complement Factor H (CFH) gene has been analyzed in relation to CAD in several studies with conflicting results. The aim of the present study was to investigate the association between the CFH Y402H polymorphism and CAD in Chinese. Methods and results About 336 patients were enrolled, included 166 patients with CAD and 170 controls. The SNP at CFH Y402H was genotyped by ligase detection reaction and plasma levels of CFH were assayed by enzyme-linked immunosorbent assay. Analysis of genotype frequencies did not reveal any significant difference between CAD patients and controls. There were significant differences in the frequencies of C allele and C allele carriers between early-onset CAD and controls. After adjustment of clinical parameters, significant association was identified for CFH Y402H polymorphism, with C allele carriers having a higher risk of early-onset CAD than carriers of TT genotype (odds ratio [OR] 4.66, 95% CI: 1.23–17.62, P = 0.02). There was no difference of plasma CFH levels between CAD group and controls. Conclusions CFH Y402H polymorphism is associated with early-onset CAD in Chinese.
Single nucleotide polymorphism Coronary artery disease Early-onset Gene polymorphism Complement factor H
Coronary artery disease
Complement factor H
Single nucleotide polymorphism
Age-related macular degeneration
This is a preview of subscription content, log in to check access.
This study was supported by Jiangsu Social Development Grant for 2007 (BS2007047).
Weng L, Kavaslar N, Ustaszewska A et al (2005) Lack of MEF2A mutations in coronary artery disease. J Clin Invest 115:1016–1020PubMedGoogle Scholar
Kardys I, Klaver CC, Despriet DD et al (2006) A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47:1568–1575. doi:10.1016/j.jacc.2005.11.076PubMedCrossRefGoogle Scholar
Brantley MA Jr, Fang AM, King JM et al (2007) Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 114:2168–2173. doi:10.1016/j.ophtha.2007.09.008PubMedCrossRefGoogle Scholar
Sepp T, Khan JC, Thurlby DA et al (2006) Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47:536–540. doi:10.1167/iovs.05-1143PubMedCrossRefGoogle Scholar
Stark K, Neureuther K, Sedlacek K et al (2007) The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clin Sci (Lond) 113:213–218. doi:10.1042/CS20070028CrossRefGoogle Scholar
Thakkinstian A, Han P, McEvoy M et al (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15:2784–2790. doi:10.1093/hmg/ddl220PubMedCrossRefGoogle Scholar
Meng W, Hughes A, Patterson CC et al (2007) Genetic variants of complement factor H gene are not associated with premature coronary heart disease: a family-based study in the Irish population. BMC Med Genet 8:62. doi:10.1186/1471-2350-8-62PubMedCrossRefGoogle Scholar